Grant opportunity · PAR-25-101
Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional)
Who can apply (as listed)
- City or township governments
- Public housing authorities / Indian housing authorities
- State governments
- Native American tribal governments (federally recognized)
- Special district governments
- Others (see the opportunity text)
- Public and state-controlled institutions of higher education
- Nonprofits without 501(c)(3) status (other than institutions of higher education)
- For-profit organizations (other than small businesses)
- County governments
- Nonprofits with 501(c)(3) status (other than institutions of higher education)
- Private institutions of higher education
- Independent school districts
- Native American tribal organizations (other than federally recognized governments)
- Small businesses
The National Institute on Drug Abuse (NIDA) Cutting-Edge Basic Research Award (CEBRA) is designed to foster highly innovative or conceptually creative research related to the etiology, pathophysiology, prevention, or treatment of substance use disorders (SUDs). It supports high-risk and potentially high-impact research that is sparse or not included in NIDA's current portfolio that has the potential to transform SUD research. The proposed research should: 1. develop, and/or adapt, revolutionary techniques or methods for addiction research or that show promising future applicability to SUD research; and /or 2. test an innovative and significant hypothesis for which there are scant precedent or preliminary data and which, if confirmed, would transform current thinking.
Excerpt as published. The full synopsis, required forms, and any amendments are on the official listing.
GrantSet indexes public records and is not the official application channel. Responses and applications go through Grants.gov only — the official notice there controls if anything shown here differs.